key: cord-0711540-wvkovrht
authors: Charoenngam, Nipith; Shirvani, Arash; Reddy, Niyoti; Vodopivec, Danica M.; Apovian, Caroline M.; Holick, Michael F.
title: Authors’ reply: Vitamin D sufficiency and COVID-19: is vitamin D binding protein (and its polymorphism) the missing link?
date: 2021-04-02
journal: Endocr Pract
DOI: 10.1016/j.eprac.2021.03.016
sha: 198fe66deb224ad0d6f1138a779dd885c1ef1016
doc_id: 711540
cord_uid: wvkovrht

nan

We would like to thank Speeckaert et al. for their interest in our study and for providing an insightful perspective on vitamin D binding protein (DBP) level or polymorphism as a possible explanation for the association between vitamin D status and COVID-19 outcomes.

The authors mentioned their previous study that the DBP1 allele frequency, which affects DBP concentration, was associated with lower prevalence and mortality of COVID-19 (1).

They further brought evidence to support their conclusion that DBP has an independent biological effect on actin scavenging which is thought to be protective against the development and severity of acute respiratory distress syndrome (ARDS). Therefore, DBP concentration or certain polymorphisms that affect the circulating concentration of DBP and thus total serum 25-hydroxyvitamin D [25(OH)D] level might be one of the unaddressed potential confounders in our analysis.

We agree with Speeckaert et al. that DBP polymorphism or concentration along with multiple other unmeasured confounders such as physical activity, sunlight exposure, nutritional intake and occult comorbidities could be a possible link for the association between vitamin D status and COVID-19 outcomes that we observed which has been replicated in several studies (2) . Therefore, we performed additional statistical analysis to determine the E-value for each statistically significant outcome. The E-value indicates the minimum effect size on the odds ratio scale that an imaginary unmeasured confounder would have to have with both the exposure and outcome to null the observed association. As shown in the Table, it 

Vitamin D sufficiency and COVID-19: is vitamin D binding protein (and its polymorphism) the missing link? Endocrine practice

Association of vitamin D status with hospital morbidity and mortality in adult hospitalized COVID-19 patients

Vitamin D and Its Potential Benefit for the COVID-19 Pandemic

Vitamin D binding protein polymorphism and COVID-19

The role of DBP gene polymorphisms in the prevalence of new coronavirus disease 2019 infection and mortality rate